Torpedo Therapeutics
YC W22Boston, US · Founded 2018 · 5 employees · 1 known investors
Torpedo Therapeutics develops high-precision, closed-loop deep brain stimulation devices for treating neurological disorders including Parkinson's disease, essential tremor, dystonia, and drug-resistant epilepsy. The company uses micro- and nano-fabrication to create ultra-small electrode leads with machine learning-driven parameter adjustment to reduce side effects and improve treatment efficacy.
Founders & leadership· Y Combinator alumni (W22)
Ingrid van Weliein𝕏Founder